IGM MGUS

Clinical trials for IGM MGUS explained in plain language.

Never miss a new study

Get alerted when new IGM MGUS trials appear

Sign up with your email to follow new studies for IGM MGUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Promising combo tackles nerve pain in rare blood conditions

Disease control Ongoing

This study tests whether adding acalabrutinib to standard rituximab therapy is safe and effective for people with nerve damage (neuropathy) linked to two blood conditions: IgM MGUS or Waldenstrom macroglobulinemia. The 12 participants receive both drugs to see if the combination …

Matched conditions: IGM MGUS

Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control

Last updated May 17, 2026 08:03 UTC

IGM MGUS

Get alerted when new IGM MGUS trials appear

Promising combo tackles nerve pain in rare blood conditions